Prof Ahmet Fuat, PCCS Education and Research Lead would like to draw your attention to the CHD Research Group at Newcastle University who are conducting an interview-based research study to understand how different groups of clinicians view our current outpatient-based care of adults with congenital heart disease (ACHD).
There are now major concerns being raised at the highest level over emerging data from different sources suggesting that the extraordinary circumstances over the past year associated with the pandemic has had significant adverse consequences for the care of our people with, or at risk of, cardiovascular disease and in particular hypertension. The need to take action urgently in relation to this has never been to so important and the PCCS has an important role to play in this.
On 14th May 2021, we held our half-day virtual meeting “Current Conversations in Cardiovascular Disease”, which covered controversies and debates within CVD management across a variety of focused topics. Each session welcomed a multidisciplinary panel of speakers and featured panel discussions, audience participation, and sharing of best practice.
With much sadness, we report the passing of John B Pittard, one of the founding council members of the original PCCS. Professor Terry McCormack reports here on his loss:
Cardiovascular disease (CVD) is one of the most common causes of death in England. It's associated with health inequalities, with higher premature death rates in more deprived areas. This report highlights progress made by the health and care system in implementing NICE guidance on CVD management.
Following a survey by the The Stroke Association showing that 25% of people don’t know their personal risk level of stroke, they're asking us to pledge to make one small change to help reduce the risk and help stop stroke from being the fourth biggest cause of death in the UK.
Kathryn E Griffith, Chair of Board of Trustees PCCS and Previous Clinical Lead for Kidney Care for the RCGP worked closely with Donal and reports here on his loss:
Bayer UK recognises that this is a critical time for everyone. We would like to reassure you that we are making every effort to support healthcare professionals, the NHS and patients through digital routes.
It will be self-evident to any cardiologist that many of our patients also suffer from diabetes and its complications. In the past care has tended to be silo specific with many cardiologists not paying a great deal of attention to the management of diabetes but this is changing with the development of drugs for diabetes that directly impact on cardiovascular outcomes.
Tuesday, 7th July 2020
19:30 – 20:30
Registration FOC: here
1 CPD credit awarded.
Hosted and supported by Primary Care Cardiovascular Society & Thrombosis UK, the webinar is
open to all healthcare and allied professionals but will be of particular interest to those working in General Practice and the community, including care homes, and managing patients with a diagnosis or suspected history of COVID-19.
We are delighted to announce that we have a new member of the PCCS Council: Trudie Lobban MBE, FRCP Edin
Please click here to download the service framework for the care of patients with heart valve disease.
The PCCS, alongside a number of other societies and associations across the UK, has come together to provide guidance on the safe switching of warfarin to DOACs.
We are delighted to announce that Dr Matt Fay has agreed to join the PCCS Council forthwith. Matt will be a great addition to the team and it’s a privilege to have a major figure in national primary care cardiology joining us.
We are hearing that fewer people are being seen in hospital with heart attacks, strokes and heart failure in recent weeks, which suggests that people are not seeking help when they should do.
Please follow the following link to see a position statement from the British Heart Valve Society regarding heart valve disease during the Coronavirus pandemic:
The British Cardiovascular Society (BCS) together with the British Society for Heart Failure (BSH) have released the following joint statement
Issues & Answers in Primary Care Today – CVplus: Because CVD is never alone 20-21 November 2020, Jurys Inn Hinckley Island Hotel & Conference Venue
BHVS Valve Clinic Study Day - 23rd June 2020
Crowne Plaza, Birmingham
British Society for Heart Failure's 10th Annual Heart Failure Nurse and Healthcare Professionals Education Day
Professor Ahmet Fuat will be presenting at the European Primary Care Cardiovascular Society - Annual Cardiovascular Summit for Primary Care on March 19th - 20th - Prague, Czech Republic
We are delighted to announce that we have a new member of the PCCS Council:
Dr Paul Ferenc GP and GPSI in Cardiology.
Graduated from Birmingham and completed foundation years in the North West, where he undertook a cardiology house job until moving to Worcestershire to undertake GP training. Since 2015 Dr Ferenc has been working at the local hospital as a GPwSI in cardiology with the local cardiology team.
The PCCS 2nd Annual Conference ‘Cardiovascular Guidelines into Practice’ took place on Thursday 16th May at the Hallam Conference Centre in Central London. A 70 strong multidisciplinary attendance of GPs, nurses, pharmacists and other health care professionals involved in cardiovascular disease care from across the UK were treated to a day of high quality and entertaining education.
The meeting was opened by our President Professor Ahmet Fuat who outlined the program, reiterated the aims of the PCCS and informed us of PCCS Board changes to take place formally at our AGM at the PCCJ meeting in Nottingham in November. Professor Ahmet Fuat, Dr Kathryn Griffith (Secretary) and Professor Michael Norton (Treasurer) will stand down to allow President-Elect Dr Jim Moore, Secretary-Elect Helen Williams and Treasurer-Elect Dr Richard Blakey to take over. Professor Fuat with stay on as immediate Past President, Professor Norton as an observer member
with a remit in Resuscitation Medicine and Dr Griffith will stand down completely. Two new board members will be elected and announced soon. Prof Fuat extended a deep debt of gratitude to both colleagues and in particular Kathryn who has put so much into the Society over many years. Thank you Kathryn.
The meeting was opened by Dr Matt Kearney NHSE National Clinical Director for CVD Prevention. His main message was that primary care needs to work differently using pharmacists, nurses and others to increase detection and management of hypertension, atrial fibrillation, lipids, familial hypercholesterolaemia and heart failure. This he said was imperative to address the recent National picture of a slowing down of CVD mortality and morbidity and close the detection and treatment gap in the priority areas outlined above. He felt the PCCS were central to CVD Leadership and implementation
of the proposed CVD Prevention Program and emerging Primary Care Networks
(PCNs) which will be expected to deliver to drive up CVD care standards.
There followed six sessions addressing diagnosis and management of patients presenting with common primary care symptoms and signs including palpitations, breathlessness, raised blood pressure, coronary artery disease with residual CV risk, diabetic patient with high CVD risk and a patient with a raised cholesterol. Real life case studies were outlined by session chairs, followed by presentations on diagnostic work up, guidelines and practical examples from around the country of how guidelines had been put into practice. All sessions were expertly presented and generated considerable
debate amongst our lively and interactive audience.
We would like to thank all of the speakers that contributed to the day and in particular the following:
Primary Care Cardiovascular Journal
British Society for Heart Failure
The British and Irish Hypertension Society
The British Cardiac Society
The Primary Care Diabetes Society
British Heart Foundation
AHSN North East
Finally we wouldn’t have been able to run such a fantastic day if it hadn’t been for our industry sponsors
Please watch this space for further opportunities to download the slides.
Please come and see us at this year's PCCJ conference - Issues & Answers in Cardiovascular Disease, 16th-17th November 2018, East Midlands Conference Centre, Nottingham.
Our stand will be in the main hall, plus our session this year is:
Updated NICE Heart Failure guidelines - furthering evidence or a missed opportunity
17.30-18.40, Conference Suite 1.
This will be immediately followed by our AGM from 18.40 - 19.15.
We look forward to seeing you there.